EMICIZUMAB
Tracking # 20-810967
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
EMICIZUMAB IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF HEMOPHILIA A. IT BELONGS TO THE BISPECIFIC MONOCLONAL ANTIBODY CLASS OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, MECHANISM OF ACTION, AND ADVERSE EVENTS ASSOCIATED WITH EMICIZUMAB ADMINISTRATION IN THE TREATMENT OF HEMOPHILIA A. THIS ACTIVITY ALSO HIGHLIGHTS DRUG MONITORING AND RELEVANT INTERFERENCES WITH COAGULATION ASSAYS, WHICH ARE PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH HEMOPHILIA A.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.25h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.25h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.25h
AMA Category I
Physician Assistant
1.25h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.25h
AMA Category I